BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30830361)

  • 41. A plasma metabolite panel as biomarkers for early primary breast cancer detection.
    Yuan B; Schafferer S; Tang Q; Scheffler M; Nees J; Heil J; Schott S; Golatta M; Wallwiener M; Sohn C; Koal T; Wolf B; Schneeweiß A; Burwinkel B
    Int J Cancer; 2019 Jun; 144(11):2833-2842. PubMed ID: 30426507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multi-b-value diffusion weighted imaging for preoperative evaluation of risk stratification in early-stage endometrial cancer.
    Zhang Q; Yu X; Lin M; Xie L; Zhang M; Ouyang H; Zhao X
    Eur J Radiol; 2019 Oct; 119():108637. PubMed ID: 31446209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
    Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
    Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The WID-EC test for the detection and risk prediction of endometrial cancer.
    Barrett JE; Jones A; Evans I; Herzog C; Reisel D; Olaitan A; Mould T; MacDonald N; Doufekas K; Newton C; Crosbie EJ; Bjørge L; Colombo N; Dostalek L; Costas L; Peremiquel-Trillas P; Ponce J; Matias-Guiu X; Zikan M; Cibula D; Wang J; Sundström K; Dillner J; Widschwendter M
    Int J Cancer; 2023 May; 152(9):1977-1988. PubMed ID: 36533702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel serum metabolomics-based diagnostic approach for colorectal cancer.
    Nishiumi S; Kobayashi T; Ikeda A; Yoshie T; Kibi M; Izumi Y; Okuno T; Hayashi N; Kawano S; Takenawa T; Azuma T; Yoshida M
    PLoS One; 2012; 7(7):e40459. PubMed ID: 22792336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 47. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum metabolomics of laryngeal cancer based on liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Zhang X; Hou H; Chen H; Liu Y; Wang A; Hu Q
    Biomed Chromatogr; 2018 May; 32(5):e4181. PubMed ID: 29272549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in endometrial cancer protein biomarkers for use in the clinic.
    Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
    Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolomic identification of novel diagnostic biomarkers in ectopic pregnancy.
    Turkoglu O; Citil A; Katar C; Mert I; Kumar P; Yilmaz A; Uygur DS; Erkaya S; Graham SF; Bahado-Singh RO
    Metabolomics; 2019 Oct; 15(11):143. PubMed ID: 31630278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of potential serum markers for endometrial cancer using protein expression profiling.
    Takano M; Kikuchi Y; Asakawa T; Goto T; Kita T; Kudoh K; Kigawa J; Sakuragi N; Sakamoto M; Sugiyama T; Yaegashi N; Tsuda H; Seto H; Shiwa M
    J Cancer Res Clin Oncol; 2010 Mar; 136(3):475-81. PubMed ID: 19756734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study.
    Gelaye B; Sumner SJ; McRitchie S; Carlson JE; Ananth CV; Enquobahrie DA; Qiu C; Sorensen TK; Williams MA
    PLoS One; 2016; 11(6):e0156755. PubMed ID: 27300725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pretreatment triglycerides-to-high density lipoprotein cholesterol ratio in postmenopausal women with endometrial cancer.
    Luo YZ; Yang Z; Qiu YL; Li XH; Qin LQ; Su QS; Mo WN
    Kaohsiung J Med Sci; 2019 May; 35(5):303-309. PubMed ID: 30887645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Artificial intelligence and the analysis of multi-platform metabolomics data for the detection of intrauterine growth restriction.
    Bahado-Singh RO; Yilmaz A; Bisgin H; Turkoglu O; Kumar P; Sherman E; Mrazik A; Odibo A; Graham SF
    PLoS One; 2019; 14(4):e0214121. PubMed ID: 30998683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Serum Markers of Esophageal Adenocarcinoma by Global and Targeted Metabolic Profiling.
    Sanchez-Espiridion B; Liang D; Ajani JA; Liang S; Ye Y; Hildebrandt MA; Gu J; Wu X
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1730-1737.e9. PubMed ID: 25998788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
    Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The metabolomic detection of lung cancer biomarkers in sputum.
    Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
    Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker.
    Ihata Y; Miyagi E; Numazaki R; Muramatsu T; Imaizumi A; Yamamoto H; Yamakado M; Okamoto N; Hirahara F
    Int J Clin Oncol; 2014 Apr; 19(2):364-72. PubMed ID: 23700142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
    Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
    Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.